{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:26:05Z","timestamp":1794014765536,"version":"4.8.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002024","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T13:42:45Z","timestamp":1464097365000},"page":"e1002024","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":157,"title":["Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study"],"prefix":"10.1371","volume":"13","author":[{"given":"Laurence","family":"Fardet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"L Fardet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"RA Overman","year":"2013","journal-title":"Arthritis Care Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"AE Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"P Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10067-013-2408-y","article-title":"Tuberculosis infection in primary Sj\u00f6gren\u2019s syndrome: a nationwide population-based study","volume":"33","author":"YS Chang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/605637","article-title":"Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study","volume":"49","author":"N Fern\u00e0ndez-Sab\u00e9","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/annrheumdis-2012-202758","article-title":"Adverse outcomes after major surgery in patients with systemic lupus erythematosus: a nationwide population-based study","volume":"73","author":"JA Lin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"MS Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","article-title":"Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients","volume":"12","author":"MR O\u2019Donnell","year":"1994","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study","volume":"44","author":"AY Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref11","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"BT Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research","volume":"16","author":"JD Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","article-title":"British National Formulary","year":"2016"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"J Chisholm","year":"1990","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"S Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref16","unstructured":"Division of Pharamacoepidemiology and Pharmacoeconomics. Sensitivity analysis of confounding: April 20, 2008. Boston: Brigham and Women\u2019s Hospital. 2008 Apr 20 [cited 16 Nov 2015]. Available: http:\/\/www.drugepi.org\/dope-downloads\/#Sensitivity%20Analysis<\/ext-link>."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/acr.21569","article-title":"Incidence of infections in patients with giant cell arteritis: a cohort study","volume":"64","author":"M Durand","year":"2012","journal-title":"Arthritis Care Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","article-title":"The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study","volume":"70","author":"M Durand","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/ar3453","article-title":"The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses","volume":"13","author":"WG Dixon","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","article-title":"Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis","volume":"65","author":"J Widdifield","year":"2013","journal-title":"Arthritis Care Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1470-2045(02)00773-8","article-title":"Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue","volume":"3","author":"S Vento","year":"2002","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/art.23112","article-title":"The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom","volume":"57","author":"AL Smitten","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2474-13-158","article-title":"Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study","volume":"13","author":"WA Blumentals","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jfma.2011.04.005","article-title":"Factors associated with development of complications among adults with influenza: a 3-year prospective analysis","volume":"111","author":"UI Wu","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.00015512","article-title":"Differences between asthmatics and nonasthmatics hospitalised with influenza A infection","volume":"41","author":"P Myles","year":"2013","journal-title":"Eur Respir J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1542\/peds.2005-0219","article-title":"Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia","volume":"116","author":"G Hill","year":"2005","journal-title":"Pediatrics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.92.2.223","article-title":"Severe varicella associated with steroid use","volume":"92","author":"SF Dowell","year":"1993","journal-title":"Pediatrics"},{"key":"ref28","first-page":"23","article-title":"Majocchi\u2019s granuloma (due to therapy with steroid and occlusion)","volume":"38","author":"PH Jacobs","year":"1986","journal-title":"Cutis"},{"key":"ref29","first-page":"507176","article-title":"Majocchi\u2019s granuloma after topical corticosteroids therapy","author":"FQ Li","year":"2014","journal-title":"Case Rep Dermatol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archderm.134.2.143","article-title":"Ivermectin for crusted Norwegian scabies induced by use of topical steroids","volume":"134","author":"F Jaramillo-Ayerbe","year":"1998","journal-title":"Arch Dermatol"},{"key":"ref31","first-page":"1165","article-title":"Norwegian scabies following topical corticosteroid therapy","volume":"17","author":"R Lipitz","year":"1981","journal-title":"Isr J Med Sci"},{"key":"ref32","first-page":"514","article-title":"Norwegian scabies in acute SLE patient treated with high dose corticosteroid","volume":"57","author":"P Timpatanapong","year":"1974","journal-title":"J Med Assoc Thai"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4161\/viru.2.4.16764","article-title":"Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species","volume":"2","author":"SC-A Chen","year":"2011","journal-title":"Virulence"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00437652","article-title":"Effect of growth of Candida spp. in the presence of various glucocorticoids on the adherence to human buccal epithelial cells","volume":"98","author":"MA Ghannoum","year":"1987","journal-title":"Mycopathologia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2008.717","article-title":"Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"MB Drummond","year":"2008","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/cid\/cit472","article-title":"Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study","volume":"57","author":"DT Eurich","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1378\/chest.13-0871","article-title":"Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study","volume":"144","author":"T McKeever","year":"2013","journal-title":"Chest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1093\/rheumatology\/keq200","article-title":"Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study","volume":"49","author":"VS Sch\u00e4fer","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis","volume":"71","author":"WG Dixon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"D Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(71)92738-3","article-title":"Prednisone side-effects and serum-protein levels. A collaborative study","volume":"2","author":"GP Lewis","year":"1971","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2125.2006.02642.x","article-title":"Patients\u2019 knowledge of adverse reactions to current medications","volume":"62","author":"G Cullen","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"ref43","unstructured":"National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guidelines [CG101]. 2010 June [cited 1 May 2015]. Available: https:\/\/www.nice.org.uk\/guidance\/cg101\/<\/ext-link>."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1097\/MD.0000000000000647","article-title":"Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study","volume":"94","author":"L Fardet","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"N Duru","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T03:48:32Z","timestamp":1656560912000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002024"}},"subtitle":[],"editor":[{"given":"Richard","family":"Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002024","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]}}}